Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02686749 · ClinicalTrials.gov registry record · Phase 4
Catheter Ablation vs. Medical Therapy in Congested Hearts With AF
A Phase 4 study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- Phase 4
- Development phase
- 4
- Enrollment target
NCT02686749: Clinical Trial Phase 4 study, sponsored by The Cleveland Clinic.
NCT02686749 is a Phase 4 study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 4 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02686749, a Phase 4 study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 4 participants
- Enrollment target
Study Summary
This study is a multi-center, randomized, unblinded, clinical trial. The objective is to determine if catheter-based atrial fibrillation (AF) ablation is superior to medical treatment in patients with impaired left ventricular (LV) function who have been diagnosed with symptomatic AF within the past 12 months.
Primary Outcome
Time measured in days to first hospitalization for heart failure, recurrence of AF or Direct Current cardioversion after the treatment period (first 3 months post enrollment or post procedure during which repeat ablation can be performed and titration of AADs can be performed).
Interventions
- DEVICE Catheter Ablation
- DRUG FDA approved anti arrhythmic drug
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2016-06 |
| Est. Completion | 2018-10-01 |
| Phase | Phase 4 |
Why NCT02686749 stopped before completion
NCT02686749 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Catheter Ablation is the first listed.
NCT02686749 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02686749 about?
NCT02686749 is a clinical study titled "Catheter Ablation vs. Medical Therapy in Congested Hearts With AF". This study is a multi-center, randomized, unblinded, clinical trial. The objective is to determine if catheter-based atrial fibrillation (AF) ablation is superior to medical treatment in patients with impaired left ventricular (LV) function who have been diagnosed with symptomatic AF within the past...
What is the current status of trial NCT02686749?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 4 participants. The study started on 2016-06. Estimated completion is 2018-10-01.
What interventions are being tested in trial NCT02686749?
The interventions under investigation include: Catheter Ablation (DEVICE), FDA approved anti arrhythmic drug (DRUG).
Who is sponsoring clinical trial NCT02686749?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02686749's enrollment target sits among peer trials
4 1994th of 2000 higher than 6 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia